Lantern Pharma, Inc.

The momentum for this stock is not very good. Lantern Pharma, Inc. is not very popular among insiders. Lantern Pharma, Inc. is a mediocre stock to choose.

News

Lantern Pharma Inc. (NASDAQ:LTRN) Sees Significant Growth in Short Interest

Zolmax Lantern Pharma Inc. (NASDAQ:LTRN - Get Free Report) was the target of a significant increase in short interest in August. As of August 15th, there was short interest totalling 233,000 shares, an...\n more…

Lantern Pharma Inc. (NASDAQ:LTRN) Short Interest Up 11.0% in August

Ticker Report Lantern Pharma Inc. (NASDAQ:LTRN - Get Free Report) saw a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 233,000 shares, an...\n more…

Lantern Pharma Inc. (NASDAQ:LTRN) Short Interest Update

Zolmax Lantern Pharma Inc. (NASDAQ:LTRN - Get Free Report) saw a large decrease in short interest in the month of July. As of July 31st, there was short interest totalling 210,000 shares, a decrease of...\n more…

Q3 2024 EPS Estimates for Lantern Pharma Inc. Increased by Zacks Small Cap (NASDAQ:LTRN)

Zolmax Lantern Pharma Inc. (NASDAQ:LTRN - Free Report) - Research analysts at Zacks Small Cap boosted their Q3 2024 earnings estimates for Lantern Pharma in a research report issued to clients and...\n more…

Lantern Pharma Inc. 2024 Q2 - Results - Earnings Call Presentation

SeekingAlpha Lantern Pharma Inc. 2024 Q2 - Results - Earnings Call Presentation...\n more…

Lantern Pharma Inc. (LTRN) Q2 2024 Earnings Call Transcript

Seeking Alpha: Transcripts Lantern Pharma Inc. (LTRN) Q2 2024 Earnings Call Transcript...\n more…